Search results
New Trials in Prostate Cancer: Could Your Patient Benefit?
Medscape· 4 days agoPerhaps one of your patients could benefit from a clinical trial that has recently opened in ...
The nine things every man should know about prostate cancer
The Telegraph via Yahoo News· 2 days agoOpening up about their below-the-belt health is not a conversation every man wants to have with his...
Cancer trends revealed, including most common types of the disease and biggest risk factors
Fox News· 4 days agoOf the 1.96 million new cancer cases in 2023, half were made up of five types: breast cancer (15%), ...
Philadelphia Medical Malpractice Attorney Weitz Delayed Cancer, Stroke Diagnosis
Digital Journal· 1 day agoMisdiagnosis or delay in diagnosis, particularly in treatable cancers such as colon cancer, prostate cancer, and pancreatic ...
Report shows Americans of Pacific island ethnicity have up to triple the rate of cancer deaths
Medical Xpress· 2 days agoThe American Cancer Society (ACS) today released Cancer Facts & Figures for Asian American, Native...
King Charles to resume public duties after 'progress' in cancer treatment
NBC NEWS· 7 days agoCharles, 75, has been restricting himself to private duties since being diagnosed in February with...
Am I at risk of bladder cancer? Symptoms of a 'forgotten' disease that impacts 1,000s of Canadians...
Yahoo Canada Style· 2 days agoWhat are the signs and symptoms of bladder cancer, and what are its risk factors? For Bladder Cancer...
King Charles takes first positive step in long journey to cancer recovery
Daily Telegraph· 7 days agoFor all the bombastic talk of cancer being “cured”, or of being given “the all-clear”, the truth is...
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050
FOX 59 Indianapolis· 2 days agoWhile five-year cancer survival rates are on an upward trend, the biotech sector is racing to meet...
The future of oncology therapies: Stingray Therapeutics’ immune-boosting breakthrough
Digital Journal· 3 days agoCurrent immune oncology treatments face a critical limitation: they are only effective in about half...